Daihan Pharmaceutical Co., Ltd. logo

Daihan Pharmaceutical Co., Ltd. (023910)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
27,000. 00
+150
+0.5587%
170.23B Market Cap
- P/E Ratio
3,600% Div Yield
3,408 Volume
- Eps
26,850
Previous Close
Add Transaction
Day Range
26,850 27,350
Year Range
24,000 31,700
Want to track 023910 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Daihan Pharmaceutical Co., Ltd. (023910) Statistics

Valuation metrics

Market Cap 170.23B
Enterprise value 111.66B
Trailing P/E (ttm) 5.89
Forward P/E -
PEG ratio -0.32
Price/Sales (ttm) 0.75
Price/Book (mrq) 0.53
Enterprise Value/Revenue 0.53
Enterprise Value/EBITDA 2.66

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.86K
Average volume (90 days) 13.13K

Price summary

52-Week low 24,000
52-Week high 31,700
Beta -
50-Day moving average 25,655.71
200-Day moving average 27,784.81

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 900
Trailing annual dividend yield 0.0333%
5-Year annual dividend yield -
Payout ratio 0.19
Dividend Date 17 Apr 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 10:1
Last split Date 29 Apr 2002

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.13%
Operating margin 0.14%

Operational effectiveness

Return on assets 0.08%
Return on equity 0.09%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 35,946.91
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 4,586.6
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 16,773.22
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 3.61%
Book value per share (mrq) 51,200.17

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -